Pancreatic Cancer Research

ResearcherJiaxing UniversityActive in the last 2 years

Fei Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0243-2758; OpenAlex author ID A5100405417. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
12
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 5

  1. Apolipoprotein E is a prognostic factor for pancreatic cancer and associates with immune infiltration. Co-author DOI 10.1016/j.cyto.2024.156628↗
  2. microRNA-26a represses pancreatic cancer cell malignant behaviors by targeting E2F7. Last author DOI 10.1007/s12672-021-00448-z↗
  3. microRNA-26a Inhibits the Malignant Tumor Behavior of Pancreatic Cancer Cells via Targeting E2F7 Last author DOI 10.21203/rs.3.rs-37425/v1↗
  4. Novel three‑lncRNA signature predicts survival in patients with pancreatic cancer. Co-author DOI 10.3892/or.2018.6761↗
  5. miR-509-5p inhibits cellular proliferation and migration via targeting MDM2 in pancreatic cancer cells. Last author DOI 10.2147/ott.s130378↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhengwei Song · 2 shared papers, 2018–2024 · strength 0.34
  2. Xiaoguang Wang · 1 shared paper, 2024 · strength 0.26
  3. Bin Wu · 1 shared paper, 2024 · strength 0.26
  4. Liang Wang · 1 shared paper, 2021 · strength 0.22
  5. Liang Wang · 1 shared paper, 2020 · strength 0.19
  6. Yan Li · 1 shared paper, 2017 · strength 0.09
  7. Xin Li · 1 shared paper, 2017 · strength 0.09
  8. Zhengxiang Zhong · 1 shared paper, 2018 · strength 0.08
  9. Xiaoguang Wang · 1 shared paper, 2018 · strength 0.08
  10. Bin Wu · 1 shared paper, 2018 · strength 0.08
  11. Jun Gao · 1 shared paper, 2018 · strength 0.08
  12. Kaixuan Wang · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.